Cowen Financial Products Reports 2.7M Share Stake in Adicet Bio

TL;DR

**Cowen Financial Products now owns 2.7M shares of Adicet Bio, a notable institutional position.**

AI Summary

Cowen Financial Products LLC, a New York-based financial firm, filed an amended SC 13G/A on February 2, 2024, disclosing a beneficial ownership of 2,715,278 shares of Adicet Bio Inc. common stock as of December 29, 2023. This filing indicates Cowen Financial Products LLC holds sole voting and dispositive power over these shares. This matters to investors because it shows a significant institutional holder's position in Adicet Bio, potentially influencing stock stability or future trading activity.

Why It Matters

This filing reveals a major institutional investor's updated stake in Adicet Bio, which can signal confidence or a shift in their investment strategy, potentially impacting the stock's perceived value.

Risk Assessment

Risk Level: low — This filing is an update on an existing institutional holding and does not indicate any immediate negative or positive event for the company.

Analyst Insight

Investors should note Cowen Financial Products LLC's continued significant stake in Adicet Bio, suggesting institutional interest. While not a direct buy signal, it's a data point for evaluating institutional confidence in the company.

Key Numbers

• 2,715,278 — Shares Beneficially Owned (Represents the total number of Adicet Bio Inc. common shares Cowen Financial Products LLC has sole voting and dispositive power over as of December 29, 2023.)
• 007002108 — CUSIP Number (Identifies the specific class of securities (Adicet Bio Inc. common stock) being reported.)

Key Players & Entities

• Cowen Financial Products LLC (company) — the reporting person beneficially owning shares of Adicet Bio Inc.
• Adicet Bio, Inc. (company) — the subject company whose common stock is being reported
• 2,715,278 (dollar_amount) — the number of shares beneficially owned by Cowen Financial Products LLC
• December 29, 2023 (date) — the date of the event requiring the filing of this statement
• February 2, 2024 (date) — the filing date of the SC 13G/A amendment

Forward-Looking Statements

• Cowen Financial Products LLC will maintain a significant stake in Adicet Bio Inc. for the foreseeable future. (Cowen Financial Products LLC) — medium confidence, target: Q3 2024

FAQ

Filing Documents

• aceta2_20224.htm (SC 13G/A) — 25KB
• 0001085146-24-000635.txt ( ) — 27KB

(a)

ITEM 1(a). NAME OF ISSUER: Adicet Bio Inc.

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 200 Clarendon St. Fl 6 Boston, MA 02116

(a)

ITEM 2(a). NAME OF PERSON FILING: Cowen Financial Products LLC

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 599 Lexington Ave. New York, NY 10022

(c)

ITEM 2(c). CITIZENSHIP: USA

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: common stock

(e)

ITEM 2(e). CUSIP NUMBER: 007002108 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 2,715,278 (b) Percent of class: 6.29% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Cowen Financial Products LLC : 2,715,278 (ii) shared power to vote or to direct the vote: Cowen Financial Products LLC : (iii) sole power to dispose or direct the disposition of: Cowen Financial Products LLC : 2,715,278 (iv) shared power to dispose or to direct the disposition of: Cowen Financial Products LLC : ITEM 5. If this statement is being filed to report the fact that as of the da

View Full Filing

View this SC 13G/A filing on SEC EDGAR